The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PD-1 inhibitor-related pneumonitis in advanced cancer patients.
 
Mizuki Nishino
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Canon USA (Inst); Merck (Inst)
 
Nikhil H. Ramaiya
No Relationships to Disclose
 
Mark M. Awad
Consulting or Advisory Role - Abbvie; AstraZeneca/MedImmune; Boehringer Ingelheim; Clovis Oncology; Genentech; Merck; Pfizer
 
Jennifer A Maattala
No Relationships to Disclose
 
Myriam Taibi
No Relationships to Disclose
 
Hiroto Hatabu
Research Funding - AZE (Inst); Canon USA (Inst); Konica Minolta (Inst); Toshiba (Inst)
 
Patrick Alexander Ott
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb
Research Funding - ARMO BioSciences (Inst); Bristol-Myers Squibb (Inst); Merck (Inst)
 
Philippe Armand
Consulting or Advisory Role - Bristol-Myers Squibb; Infinity Pharmaceuticals; Merck Sharp & Dohme
Research Funding - Bristol-Myers Squibb; Merck Sharp & Dohme; Otsuka; Sequenta; Sigma-Tau; Tensha Therapeutics
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme; Sequenta
 
F. Stephen Hodi
Consulting or Advisory Role - Amgen; Genentech/Roche; Merck Sharp & Dohme; Novartis
Research Funding - bristol-myers squibb (Inst); Genentech/Roche (Inst); Merck Sharp & Dohme (Inst); novartis (Inst)
Patents, Royalties, Other Intellectual Property - patent pending as per institutional policy; patent pending royalties received on MICA related disorders application to institution per institutional IP policy
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
Other Relationship - Bristol-Myers Squibb; Genentech/Roche